gsk rsv vaccine - Search News

Order byBest matchMost fresh

News

GSK, RSV and European Medicines Agency

· 2d · on MSN

GSK applies to EU regulator for expanded use of RSV vaccine

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults below the age of 50 who are at risk of the disease, the British drugmaker said on Friday.

Continue reading

Medical Dialogues · 1d

GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older

GSK (LSE:GSK) Seeks European Expansion Of RSV Vaccine To Adults 18 And Older

3d

New antibody shot could help protect babies from RSV

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

5don MSN

AstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer share prices: Why are vaccine stocks down?

S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

6don MSN

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

Fierce Biotech6d

GSK snags longtime Sanofi exec to lead vaccine and infectious disease R&D

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

5don MSN

Newly approved therapy could offer another option for protecting infants from RSV, a common infection that can be deadly

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Sanofi starts shipping RSV drug early as rival nears market

Clesrovimab has been held up by MSD (known as Merck & Co in the US and Canada) as offering simpler dosing and better clinical ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results